RE: Morning all10 Oct 2025 13:57
That’s what it looks like yes imho also.
I’m hoping that the cash in the upfront payment for Altamira is transferred into Midkine so assuming base case $2m, then we’d have around 50% holding as cash.
On future payments, could we see return of capital as cash/dividends or would they look to sell the company ?
I think your questions are why we are trading so low as people can’t really value the deals until they happen. Obviously if they do happen then it’ll rerate quickly. Posts have been put on previously highlighting how the $10.8m for Lyramid could be seen as a base case valuation and it could go onto be worth multiples of that as they proceed through trials and progress. Base case it is worth 5p per share as suggested by the chairman in the presentation and the interviews recently.
Nai/DYOR